BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal myeloproliferative disorders arising from a multipotent progenitor. The loss of heterozygosity (LOH) on the short arm of chromosome 9 (9pLOH) in myeloproliferative disorders suggests that 9p harbors a mutation that contributes to the cause of clonal expansion of hematopoietic cells in these diseases. METHODS: We performed microsatellite mapping of the 9pLOH region and DNA sequencing in 244 patients with myeloproliferative disorders (128 with polycythemia vera, 93 with essential thrombocythemia, and 23 with idiopathic myelofibrosis). RESULTS: Microsatellite mapping identified a 9pLOH region that included the Janus kinase 2 (JAK2) gene. In patien...
A somatic gain-of-function mutation in exon 14 of the Janus kinase 2 (JAK2) gene is found in Philade...
Abstract. The myeloproliferative disorders, polycythemia vera, essential thombocythemia, and primary...
The molecular pathogenesis of chronic myeloproliferative disorders (MPDs) is poorly understood. The ...
BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal my...
Myeloproliferative disorders (MPDs) are heterogeneous diseases that occur at the level of a multipot...
Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the o...
SummaryPolycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibr...
An acquired somatic mutation in the JAK2 gene resulting in a valine to phenylalanine substitution at...
Tumor heterogeneity has been recognized for decades. The molecular mechanisms impacting clonal heter...
The analysis of rare chromosomal transloca-tions in myeloproliferative disorders has highlighted the...
The analysis of rare chromosomal translocations in myeloproliferative disorders has highlighted the ...
BACKGROUND. A somatic gain-of-function mutation of the Janus kinase 2 (JAK2) gene has been identifie...
Myeloproliferative disorders are clonal haematopoietic stem cell malignancies characterized by indep...
The myeloproliferative disorders polycythemia vera, essential throm-bocytosis, and primary myelofibr...
Objective/backgroundMyeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem ce...
A somatic gain-of-function mutation in exon 14 of the Janus kinase 2 (JAK2) gene is found in Philade...
Abstract. The myeloproliferative disorders, polycythemia vera, essential thombocythemia, and primary...
The molecular pathogenesis of chronic myeloproliferative disorders (MPDs) is poorly understood. The ...
BACKGROUND: Polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are clonal my...
Myeloproliferative disorders (MPDs) are heterogeneous diseases that occur at the level of a multipot...
Chronic myeloproliferative neoplasms (MPNs) are a group of related conditions characterized by the o...
SummaryPolycythemia vera (PV), essential thrombocythemia (ET), and myeloid metaplasia with myelofibr...
An acquired somatic mutation in the JAK2 gene resulting in a valine to phenylalanine substitution at...
Tumor heterogeneity has been recognized for decades. The molecular mechanisms impacting clonal heter...
The analysis of rare chromosomal transloca-tions in myeloproliferative disorders has highlighted the...
The analysis of rare chromosomal translocations in myeloproliferative disorders has highlighted the ...
BACKGROUND. A somatic gain-of-function mutation of the Janus kinase 2 (JAK2) gene has been identifie...
Myeloproliferative disorders are clonal haematopoietic stem cell malignancies characterized by indep...
The myeloproliferative disorders polycythemia vera, essential throm-bocytosis, and primary myelofibr...
Objective/backgroundMyeloproliferative neoplasms (MPNs) are heterogeneous clonal bone marrow stem ce...
A somatic gain-of-function mutation in exon 14 of the Janus kinase 2 (JAK2) gene is found in Philade...
Abstract. The myeloproliferative disorders, polycythemia vera, essential thombocythemia, and primary...
The molecular pathogenesis of chronic myeloproliferative disorders (MPDs) is poorly understood. The ...